Trials / Terminated
TerminatedNCT04556032
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
A Placebo-controlled, Randomized, Double-blind Trial to Assess the Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- Midwest Center for Metabolic and Cardiovascular Research · Academic / Other
- Sex
- All
- Age
- 55 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to assess the effects of ergothioneine at two doses, compared to placebo, on cognition, mood, and sleep in healthy adult men and women.
Detailed description
This will be a placebo-controlled, randomized, double-blind, parallel-arm trial. The study will consist of one screening (visit 1a, week 0), one baseline visit (visit 1b, week 0), and three treatment visits (visits 2, 3, and 4; weeks 4, 8, and 16).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | L-Ergothioneine 10 mg/d | L-Ergothioneine 10 mg/d |
| DIETARY_SUPPLEMENT | L-Ergothioneine 25 mg/d | L-Ergothioneine 25 mg/d |
| OTHER | Placebo | 0 mg/d L-Ergothioneine |
Timeline
- Start date
- 2020-09-09
- Primary completion
- 2020-10-30
- Completion
- 2020-10-30
- First posted
- 2020-09-21
- Last updated
- 2020-11-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04556032. Inclusion in this directory is not an endorsement.